Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value:
$201.57M
Total Bought:
$58.77M
Total Sold:
$22.89M
Net Transaction:
+$35.88M
Notable People:
Tony Michael Berta
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
argenx SEADR(ARGX)82,15092,500+10,350$35.33M$50.14M24.88%+$14.81M
Rhythm Pharmaceuticals, Inc.(RYTM)922,100663,381-258,719$37.86M$34.75M17.24%-$3.11M
Phathom Pharmaceuticals, Inc.(PHAT)875,0001,504,307+629,307$9.01M$27.20M13.49%+$18.19M
Cytokinetics, Incorporated(CYTK)190,000466,813+276,813$10.29M$24.65M12.23%+$14.35M
Axsome Therapeutics, Inc.(AXSM)290,772209,632-81,140$23.41M$18.84M9.35%-$4.57M
Avadel Pharmaceuticals Plc1,138,1781,100,000-38,178$16.00M$14.43M7.16%-$1.58M
Protagonist Therapeutics Inc355,000240,000-115,000$12.30M$10.80M5.36%-$1.50M
Pliant Therapeutics, Inc.(PLRX)232,200380,000+147,800$2.50M$4.26M2.11%+$1.76M
TScan Therapeutics, Inc.(TCRX)0825,341+825,341$0$4.11M2.04%+$4.11M
Atyr Pharma Inc1,946,4771,736,477-210,000$3.04M$3.06M1.52%+$19.7K
Soleno Therapeutics Inc19,69557,983+38,288$803.6K$2.93M1.45%+$2.12M
Cidara Therapeutics Inc145,417182,426+37,009$1.74M$1.96M0.97%+$224.8K
Stoke Therapeutics, Inc.(STOK)0157,514+157,514$0$1.94M0.96%+$1.94M
Disc Medicine, Inc.(IRON)025,543+25,543$0$1.26M0.62%+$1.26M
Trevi Therapeutics, Inc.(TRVI)500,089250,000-250,089$1.49M$835.0K0.41%-$655.3K
Allakos Inc649,957649,9570$650.0K$424.6K0.21%-$225.4K
Applied Therapeutics Inc227,4700-227,470$1.06M$0—-$1.06M
Corcept Therapeutics Incorporated(CORT)244,7500-244,750$7.95M$0—-$7.95M
Kymera Therapeutics, Inc.(KYMR)82,0000-82,000$2.45M$0—-$2.45M
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q3 2024 | TickerTrail